Depth of colorectal-wall invasion and lymph-node involvement as major outcome factors influencing surgical strategy in patients with advanced and recurrent ovarian cancer with diffuse peritoneal metastases

Di Giorgio, Angelo; Cardi, Maurizio; Biacchi, Daniele; Sibio, Simone; Accarpio, Fabio; Ciardi, Antonio; Cornali, Tommaso; Framarino, Marialuisa; Sammartino, Paolo
April 2013
World Journal of Surgical Oncology;2013, Vol. 11 Issue 1, p1
Academic Journal
Background: More information is needed on the anatomopathological outcome variables indicating the appropriate surgical strategy for the colorectal resections often needed during cytoreduction for ovarian cancer. Methods: From a phase-II study cohort including 70 patients with primary advanced or recurrent ovarian cancer with diffuse peritoneal metastases treated from November 2000 to April 2009, we selected for this study the 52 consecutive patients who needed colorectal resection. Data collected included type of colorectal resection, peritoneal cancer index (PCI), histopathology (depth of bowel-wall invasion and lymph-node spread), cytoreduction rate and outcome. Correlations were tested between possible prognostic factors and Kaplan-Meier five-year overall and disease-free survival. A Cox multivariate regression model was used to identify independent variables associated with outcome. Results: In the 52 patients, the optimal cytoreduction rate was 86.5% (CC0/1). In all patients, implants infiltrated deeply into the bowel wall, in 75% of the cases up to the muscular and mucosal layer. Lymph-node metastases were detected in 50% of the cases; mesenteric nodes were involved in 42.3%. Most patients (52%) had an uneventful postoperative course. Operative mortality was 3.8%. The five-year survival rate was 49.9% and five-year disease-free survival was 36.7%. Cox regression analysis identified as the main prognostic factors completeness of cytoreduction and depth of bowel wall invasion. Conclusions: Our findings suggest that the major independent prognostic factors in patients with advanced ovarian cancer needing colorectal resections are completeness of cytoreduction and depth of bowel wall invasion. Surgical management and pathological assessment should be aware of and deal with dual locoregional and mesenteric lymphatic spread.


Related Articles

  • Histopathological features predict metastatic potential in locally advanced colon carcinomas. Jayasinghe, Caren; Simiantonaki, Nektaria; Kirkpatrick, Charles James // BMC Cancer;2015, Vol. 15 Issue 1, p1 

    Background Metastatic dissemination can exist before a pathologically and clinically detectable manifestation. The structural heterogeneity of colon cancer (CC) in histological sections with respect to the morphology of tumor aggressiveness and composition of the tumor microenvironment raises...

  • Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer. Sawada, Kenjiro; Ohyagi-Hara, Chifumi; Kimura, Tadashi; Morishige, Ken-ichirou // Journal of Oncology;2012, p1 

    Ovarian cancer is a deadly disease, with a cure rate of only 30%. Despite aggressive treatments, relapse remains almost inevitable in patients with advanced-stage disease. In recent years, great progress has beenmade towards targeting integrins in cancer treatment, and clinical studies with...

  • Preoperative [18F]FDG PET/CT predicts recurrence in patients with epithelial ovarian cancer. Hyun Hoon Chung; Hyun Woo Kwon; Keon Wook Kang; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Soon-Beom Kang // Journal of Gynecologic Oncology;Mar2012, Vol. 23 Issue 1, p28 

    Objective: To determine whether [18F]FDG uptake on PET/CT imaging before surgical staging has prognostic significance in patients with epithelial ovarian cancer (EOC). Methods: Patients with EOC were imaged with integrated PET/CT before surgical staging. Hypermetabolic lesions were measured as...

  • How to approach patients in relapse. Pujade-Lauraine, E. // Annals of Oncology;Sep2012 Supplement 10, Vol. 23 Issue suppl_10, px128 

    No abstract available.

  • Calcified metastases from ovarian carcinoma highlighted by F-18 FDG PET/CT: report of two cases. Hu, Si-Long; Zhou, Zheng-Rong; Zhang, Ying-Jian // Abdominal Imaging;Aug2012, Vol. 37 Issue 4, p675 

    Two cases of postoperative female patients with ovarian serous papillary carcinoma were referred for F-18 Fluorodeoxyglucose (F-18 FDG) PET/CT to evaluate suspicious recurrence and/or metastasis. One patient presented with multiple extensive calcified lesions with increased FDG uptake in the...

  • Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients. El Hajj, P; Journe, F; Wiedig, M; Laios, I; Sal├Ęs, F; Galibert, M-D; Van Kempen, L C; Spatz, A; Badran, B; Larsimont, D; Awada, A; Ghanem, G // British Journal of Cancer;4/30/2013, Vol. 108 Issue 8, p1641 

    Background:Clinical outcome of high-risk melanoma patients is not reliably predicted from histopathological analyses of primary tumours and is often adjusted during disease progression. Our study aimed at extending our previous findings in skin metastases to evaluate the prognostic value of...

  • High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma. Nishida, Yoshihiro; Tsukushi, Satoshi; Urakawa, Hiroshi; Sugiura, Hideshi; Nakashima, Hiroatsu; Yamada, Yoshihisa; Ishiguro, Naoki // International Journal of Clinical Oncology;Jun2014, Vol. 19 Issue 3, p536 

    Background: Rhabdomyosarcoma has different extension patterns, including a higher propensity for lymph nodes metastasis, compared with other types of soft tissue sarcoma. The aims of this study were to investigate the patterns of regional and distant metastasis in patients with...

  • Metastasis-Associated in Colon Cancer 1 Is a Novel Survival-Related Biomarker for Human Patients with Renal Pelvis Carcinoma. Hu, Hailong; Tian, Dawei; Chen, Tao; Han, Ruifa; Sun, Yan; Wu, Changli // PLoS ONE;Jun2014, Vol. 9 Issue 6, p1 

    Metastasis-associated in colon cancer 1 (MACC1) has recently been identified as a novel independent prognostic indicator for metastasis occurrence, overall survival and cancer-free survival for patients with colon cancer and other solid tumors. In this study, we investigated the role of MACC1 in...

  • Prognostic significance of CXCL12 expression in patients with colorectal carcinoma. Yuri Akishima-Fukasawa; Yukihiro Nakanishi; Yoshinori Ino; Yoshihiro Moriya; Yae Kanai; Setsuo Hirohashi // American Journal of Clinical Pathology;Aug2009, Vol. 132 Issue 2, p202 

    The present study investigated the protein expression level of CXCL12 in colorectal cancer and aimed to elucidate its association with prognosis. CXCL12 positivity in 50% or more of tumor cells was defined as high expression and that in less than 50% of the tumor cells as low expression. CXCL12+...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics